Literature DB >> 19319536

[Hereditary and non-hereditary cutaneous amyloidoses].

S Schreml1, J Schroeder, F Eder, R M Szeimies, M Landthaler, P Babilas.   

Abstract

Amyloid and amyloidosis describes a heterogeneous group of diseases which are characterized by the pathological extracellular deposition of autologous proteins. Basically, amyloidoses can be divided into systemic or organ-limited (e.g. cutaneous) forms and can be acquired or hereditary in nature. The subclassification discriminates between primary amyloidosis (in the absence of an obvious predisposing disease) and secondary amyloidosis (if caused by a certain underlying disease). The subclassification of amyloidoses is based on the main protein constituent and therefore on the chemical composition of the amyloid fibrils. However, the exact etiopathogenesis of amyloid formation remains unclear. In addition to the clinical presentation, histology, electron microscopy and biochemical-immunological differentiation are also decisive for a proper diagnosis. In cutaneous amyloidosis the deposition of amyloid either occurs along reticulin fibers and the basal membrane (perireticulary amyloidoses) or along collagen fibers (pericollagenous amyloidosis). The purpose of this article is to provide an up-to-date overview on the different kinds of cutaneous amyloidoses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319536     DOI: 10.1007/s00292-009-1130-7

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  36 in total

1.  Poikiloderma-like cutaneous amyloidosis. Report of a case and review of the literature.

Authors:  A Ogino; S Tanaka
Journal:  Dermatologica       Date:  1977

2.  Discoid lupus erythematosus with secondary amyloidosis.

Authors:  A M Powell; S Albert; B Bhogal; M M Black
Journal:  Br J Dermatol       Date:  2005-10       Impact factor: 9.302

3.  Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type).

Authors:  C P Maury; M Liljeström; G Boysen; T Törnroth; A de la Chapelle; E L Nurmiaho-Lassila
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

4.  Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration.

Authors:  M Kumakiri; K Hashimoto
Journal:  J Invest Dermatol       Date:  1979-08       Impact factor: 8.551

5.  Frequent association between MEN 2A and cutaneous lichen amyloidosis.

Authors:  Uberta Verga; Laura Fugazzola; Stefano Cambiaghi; Chiara Pritelli; Elvio Alessi; Donatella Cortelazzi; Emanuela Gangi; Paolo Beck-Peccoz
Journal:  Clin Endocrinol (Oxf)       Date:  2003-08       Impact factor: 3.478

6.  Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis.

Authors:  Eloisa Arbustini; Laura Verga; Monica Concardi; Giovanni Palladini; Laura Obici; Giampaolo Merlini
Journal:  Amyloid       Date:  2002-06       Impact factor: 7.141

7.  Nail dystrophy and blisters as sole manifestations in myeloma-associated amyloidosis.

Authors:  Yasuyuki Fujita; Yukiko Tsuji-Abe; Kazuko C Sato-Matsumura; Masashi Akiyama; Hiroshi Shimizu
Journal:  J Am Acad Dermatol       Date:  2006-04       Impact factor: 11.527

8.  Colloid-amyloid bodies in PUVA-treated human psoriatic patients.

Authors:  K Hashimoto; M Kumakiri
Journal:  J Invest Dermatol       Date:  1979-02       Impact factor: 8.551

9.  Cutaneous amyloidosis associated with primary biliary cirrhosis.

Authors:  Jean R Tafarel; Lara B Lemos; Patrícia M Oliveira; Valéria P Lanzoni; Maria L G Ferraz
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-07       Impact factor: 2.566

10.  Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.

Authors:  E Ihse; A Ybo; Ob Suhr; P Lindqvist; C Backman; P Westermark
Journal:  J Pathol       Date:  2008-10       Impact factor: 7.996

View more
  1 in total

1.  [Unusual skin alterations in a 72-year-old patient with multiple myeloma].

Authors:  C Hart; S Wurm; C Hafner; R Andreesen; M Grube
Journal:  Internist (Berl)       Date:  2012-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.